A detailed history of Farther Finance Advisors, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 11,228 shares of ORGO stock, worth $50,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,228
Previous 9,588 17.1%
Holding current value
$50,862
Previous $35.1 Million 35.02%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$3.78 - $5.03 $6,199 - $8,249
1,640 Added 17.1%
11,228 $47.4 Million
Q2 2025

Jul 11, 2025

BUY
$2.66 - $5.34 $25,504 - $51,199
9,588 New
9,588 $35.1 Million
Q4 2022

Sep 11, 2023

BUY
$2.48 - $3.43 $649 - $898
262 New
262 $705,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $593M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.